All Stories

  1. Mpox in the Gulf Cooperation Council Countries: <i>Addressing a new challenge to regional health security</i>
  2. Influence of Culture Among Users of Illegal Drugs: An Ethnographic Study
  3. Eating Behaviors during Pregnancy: A Cross-Sectional Study
  4. Post-Traumatic Psychological Experience of COVID-19 Survivors: A Descriptive Phenomenological Study
  5. Eating Behaviors during Pregnancy: A Cross-Sectional Study
  6. Support for Mandatory COVID-19 Vaccines for Children
  7. Burden of disease scenarios for 204 countries
  8. [Review Article] Drug Use Disorder and Coping Mechanisms Due to COVID-19 Lockdown Measures: A Cross-Sectional Survey
  9. Should we be concern about the Recent Avian Influenza Outbreaks?
  10. [Review Article] Drug Use Disorder and Coping Mechanisms Due to COVID-19 Pandemic Measures: A Cross-Sectional Survey
  11. Drug Use Disorder and Coping Mechanisms Due to COVID-19 Pandemic Measures: A Cross-Sectional Survey
  12. Elimination of Mother-to-Child Transmission of Hepatitis B Virus in Gulf Cooperation Council Countries: Current Status and Future Prospects
  13. Assessing Healthcare Providers' Preparedness for Managing COVID-19 Patients: A Mixed-Methods Study
  14. Reply to Hamzavi et al. Comment on “Islam et al. Helminth Parasites among Rodents in the Middle East Countries: A Systematic Review and Meta-Analysis. Animals 2020, 10, 2342”
  15. Non-pharmaceutical Interventions (NPIs) are strategies that individuals and communities
  16. Spontaneous remission of angioimmunoblastic T‑cell lymphoma
  17. Herpes Zoster Burden of Disease and Clinical Management in Turkey: A Comprehensive Literature Review
  18. Antimicrobial Stewardship Opportunities: An Example from Oman
  19. The Progress Towards National Malaria Elimination: The Experience of Oman
  20. Forecasting smoking deaths to 2050: a forecasting analysis for the global burden of disease study
  21. This review reports on the recent epidemiology of invasive meningococcal disease (IMD) the GCC
  22. Influenza Vaccine hesitancy in EMR
  23. An outbreak of human monkeypox (Hmpox) in multiple non-endemic countries
  24. Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries
  25. Oman's COVID-19 publication trends: A cross-sectional bibliometric study
  26. The Impact of Demographic, Clinical Characteristics and the Various COVID-19 Variant Types
  27. This study aimed to assess the acceptance of COVID-19 vaccine booster doses in the countries
  28. The Role of Psychological Factors and Vaccine Conspiracy Beliefs in Influenza Vaccine Hesitancy and Uptake among Jordanian Healthcare Workers during the COVID-19 Pandemic
  29. Assessing COVID-19 Vaccine’s Acceptability Amongst Health Care Workers in Oman
  30. Alarming Antibiotic Resistance in Pediatric Oncology Patients
  31. Knowledge, Attitude, and Acceptability of COVID-19 Vaccine in Oman
  32. Improving the process of employee recognition: An exploratory study
  33. Integrated Care for the Elderly in the Primary Health Care setting Oman: The Scope and Experience
  34. Weaning Practices Impact Factors and Outcomes an experiance from Oman
  35. A Systematic Review of Influenza Epidemiology and Surveillance in the Eastern Mediterranean and North African Region
  36. Hospitalized Patients with Moderate versus Severe COVID-19 Infection
  37. Our paper illustrated the importance of influenza vaccination among DM
  38. Living-Donor Liver Transplant in Oman: A Quantitative Cross-Sectional Study of Donors’ Experiences and Challenges
  39. Epidemiological Risk Factors for Acquiring Severe COVID-19
  40. This a work done by our countries
  41. Epidemiological Characteristics of Hepatitis B Positive Patients in Oman
  42. Epidemiological Characteristics of 69,382 COVID-19 Patients in Oman
  43. An Innovative Communication Approach to Mitigate Suffering Among COVID-19 Patients and Their Families: An Experience From Oman
  44. Role of primary healthcare in the response to COVID-19
  45. Levels of Physical Activity,
  46. Community Participation Approaches for Effective National COVID-19 Pandemic Preparedness and Response: An Experience From Oman
  47. Efforts for measles elimination in the Gulf Cooperation Council countries 2015–2019: A review
  48. Helminth Parasites among Rodents in the Middle East Countries
  49. Addressing Influenza Vaccination in MENA Region during the COVID-19 Pandemic: Decreasing the Effects of the Collision
  50. Influenza Vaccination Hesitancy among Healthcare Workers in Oman
  51. Preparing the Community for an upcoming Vaccine Against COVID-19
  52. Pneumococcal Meningitis Among Children in the Post-13-Valent Pneumococcal Conjugate Vaccine Era: Three Case Reports
  53. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017
  54. COVID 19 in Oman
  55. One Health operational framework for action for the Eastern Mediterranean Region
  56. The Omani experiences in presenting the first COVID 19 cases
  57. Oman, MERS-CoV
  58. This manuscript provided information on Health promotion strategy as part of Vision 2050 in Oman
  59. This paper gives over the situation of WPV globally and specifically in Oman.
  60. Assessment of Key Performance Indicators of the Primary Health Care in Oman
  61. Zoonotic Diseases in Oman: Successes, Challenges, and Future Directions
  62. assess the impact of non-pharmaceutical interventions on the COVID-19 epidemic in Oman
  63. Hepatitis B Elimination in GHC states
  64. MERS-Cov in Oman
  65. Dengue outbreak in Oman
  66. Influenza surveillance in MENA countries
  67. EMARIS report
  68. Successes and Challenges of HIV/AIDS Program in Oman: 1984–2015
  69. TB in Oman
  70. Assessment of hepatitis B immunization programme among school students in Qatar
  71. TB Elimination in GHC states
  72. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study.
  73. Assessment of safe injection practices in health facilities in Oman
  74. Pertussis control
  75. The manuscript provided the leprosy situation in Oman and the way forward
  76. Progress towards measles, rubella and congenital rubella syndrome elimination: Oman experience
  77. Early Clinical Manifestations of CRS
  78. Late Clinical Manifestations of Congenital Rubella Syndrome
  79. Epidemiology of Pandemic H1N1 in Oman and Public Health Response, 2009
  80. Dengue epidemiological trend in Oman: a 13-year national surveillance and strategic proposition of imported cases
  81. Cost effectiveness of a pentavalent rotavirus vaccine in Oman
  82. Molecular Epidemiology and Genotyping of Hepatitis B Virus of HBsAg-Positive Patients in Oman
  83. HPV epidemiological situation in EMR
  84. Progress toward Elimination of Hepatitis B Virus Transmission in Oman: Impact of Hepatitis B Vaccination
  85. Epidemiology of invasive pneumococcal infection among hospitalized children aged less than 5 years in Oman
  86. Absence of lymphatic filariasis infection among secondary-school children
  87. The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases in the Sultanate of Oman: Evidence-based approach and consensus decision-making
  88. Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study
  89. ocular manifestations of congenital rubella syndrome
  90. Poliomyelitis in Oman. I. The last outbreak?
  91. Poliomyelitis in Oman. II. Toward eradication